Mpm Bioequities Master Fund Lp - Net Worth and Insider Trading

Mpm Bioequities Master Fund Lp Net Worth

The estimated net worth of Mpm Bioequities Master Fund Lp is at least $9 Million dollars as of 2025-06-04. Mpm Bioequities Master Fund Lp is the 10% Owner of Rigel Pharmaceuticals Inc and owns about 435,052 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $9 Million. Details can be seen in Mpm Bioequities Master Fund Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mpm Bioequities Master Fund Lp has not made any transactions after 2004-02-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Mpm Bioequities Master Fund Lp

To

Mpm Bioequities Master Fund Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mpm Bioequities Master Fund Lp owns 1 companies in total, including Rigel Pharmaceuticals Inc (RIGL) .

Click here to see the complete history of Mpm Bioequities Master Fund Lp’s form 4 insider trades.

Insider Ownership Summary of Mpm Bioequities Master Fund Lp

Ticker Company Transaction Date Type of Owner
RIGL Rigel Pharmaceuticals Inc 2004-02-19 10 percent owner

Mpm Bioequities Master Fund Lp Latest Holdings Summary

Mpm Bioequities Master Fund Lp currently owns a total of 1 stock. Mpm Bioequities Master Fund Lp owns 435,052 shares of Rigel Pharmaceuticals Inc (RIGL) as of February 19, 2004, with a value of $9 Million.

Latest Holdings of Mpm Bioequities Master Fund Lp

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RIGL Rigel Pharmaceuticals Inc 2004-02-19 435,052 20.53 8,931,618

Holding Weightings of Mpm Bioequities Master Fund Lp


Mpm Bioequities Master Fund Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Mpm Bioequities Master Fund Lp has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 17,237 shares on February 19, 2004, which brought Mpm Bioequities Master Fund Lp around $3 Million.

Insider Trading History of Mpm Bioequities Master Fund Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mpm Bioequities Master Fund Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mpm Bioequities Master Fund Lp Ownership Network

Ownership Network List of Mpm Bioequities Master Fund Lp

No Data

Ownership Network Relation of Mpm Bioequities Master Fund Lp

Insider Network Chart


Mpm Bioequities Master Fund Lp Owned Company Details

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

Mpm Bioequities Master Fund Lp is the 10 percent owner of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & GC & Corp Sec Raymond J. Furey .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, Mpm Bioequities Master Fund Lp made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 62,246 shares made by Raul R Rodriguez , a net sale of 18,440 shares made by David A Santos , and a net sale of 16,398 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 27,834 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 27,834 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

Mpm Bioequities Master Fund Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Mpm Bioequities Master Fund Lp. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mpm Bioequities Master Fund Lp's mailing address is: Boston Ma 02199.